Eli Lilly to Acquire Calytrix Bio in Deal Worth Up to $1.5 Billion
The American pharmaceutical group Eli Lilly has agreed to acquire biotechnology company Calytrix Bio for up to $1.5 billion, equivalent to around SEK 15 billion.
BusinessThe American pharmaceutical group Eli Lilly has agreed to acquire biotechnology company Calytrix Bio for up to $1.5 billion, equivalent to around SEK 15 billion.
BusinessYou're up to date in JP Morgan Life Sciences Private Capital
That's every story in JP Morgan Life Sciences Private Capital for now.